Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Courses and events
Can we expect progress from targeted therapy of SCLC?
Nevin Murray, Krista L. Noonan
Eur Respir Monogr 2015; 68: 234-246
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nevin Murray, Krista L. Noonan. Can we expect progress from targeted therapy of SCLC?. Eur Respir Monogr 2015; 68: 234-246
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight